Scientists from Sanford Burnham Prebys Medical Discovery Institute and Radboud University Medical Center have discovered new genetic mutations linked to autism spectrum disorder (ASD).
The mutations affect brain development, leading to impaired memory and learning. The study suggests that drugs restoring the function of the CNOT1 gene, where the mutations were found, may have therapeutic benefits. The CNOT1 gene interacts with known ASD genes, providing new avenues for ASD research.
This finding may lead to the development of drugs that can help children with neurodevelopmental delays caused by CNOT1 mutations. The exact causes of developmental disabilities, including ASD, remain poorly understood, and genetic variations play a role in these disabilities.
Identifying underlying causes of developmental disabilities could lead to early diagnoses and potential treatments. The research was supported by various organizations and institutions, including the Dutch Research Council and the European Union.
The original article can be found here.
You can read similar articles here.
